Please enable JavaScript to continue using this application.

Compare $MNOV vs $TENX | Chartloom

Compare

$MNOV vs $TENX

MediciNova Inc · Tenax Therapeutics Inc

MNOV

MediciNova Inc

TENX

Tenax Therapeutics Inc

Compare $MNOV vs $TENX

Comparing MediciNova Inc and Tenax Therapeutics Inc

MNOVMediciNova Inc

TENXTenax Therapeutics Inc

MNOVMediciNova Inc

Market cap

$75M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

583.8%

YTD performance

14.3%

52W performance

24.6%

FCF yield

-12.2%

TENXTenax Therapeutics Inc

Market cap

$50M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-82.9%

YTD performance

-83.1%

52W performance

-76.1%

FCF yield

-92.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MNOV

TENX

Detailed metrics comparison

MNOV

MediciNova Inc

TENX

Tenax Therapeutics Inc

Market Cap

MNOV$75M

TENX$50M

Enterprise Value

MNOV$49M

TENX$-68M

Price

MNOV$1.52

TENX$1.87

P/E Ratio

MNOVN/A

TENXN/A

P/S Ratio

MNOV81.28x

TENX1,503.03x

EV/Sales

MNOV53.67x

TENX-889.99x

EV/EBITDA

MNOV0.00x

TENX0.00x

P/B Ratio

MNOV2.35x

TENX0.65x

P/FCF Ratio

MNOVN/A

TENXN/A

EV/FCF

MNOV-5.41x

TENX1.49x

PEG Ratio

MNOVN/A

TENXN/A

Forward P/E (NTM)

MNOVN/A

TENXN/A

Forward P/S (NTM)

MNOVN/A

TENXN/A

Revenue (TTM)

MNOV$920K

TENX$0

Revenue Growth (YoY)

MNOV583.8%

TENX-82.9%

Forward Rev Growth

MNOV-2.9%

TENX111.9%

Gross Margin (TTM)

MNOV37.8%

TENX100.0%

Operating Margin (TTM)

MNOV0.0%

TENX0.0%

EBITDA Margin (TTM)

MNOV-1285.4%

TENX0.0%

Net Margin (TTM)

MNOV-1168.3%

TENX0.0%

FCF Margin (TTM)

MNOV-991.3%

TENXN/A

Net Income (TTM)

MNOV$-11M

TENX$-65M

FCF (TTM)

MNOV$-9M

TENX$-46M

EPS (TTM)

MNOV-$0.22

TENX-$1.28

ROE (TTM)

MNOV-2651.0%

TENX-6155.0%

ROA (TTM)

MNOV-2439.0%

TENX-5742.0%

ROIC (TTM)

MNOV-2651.0%

TENX-6155.0%

Cash

MNOV$25M

TENX$118M

Debt

MNOV$0

TENX$0

Net Cash/Debt

MNOV$25M

TENX$118M

Current Ratio (TTM)

MNOV8.75x

TENX15.07x

Quick Ratio (TTM)

MNOV8.58x

TENX14.65x

Debt/Equity (TTM)

MNOV0.00x

TENX0.00x

Debt/Assets (TTM)

MNOV0.0%

TENX0.0%

Interest Coverage (TTM)

MNOVN/A

TENXN/A

Net Debt/EBITDA (TTM)

MNOV0.00x

TENX0.00x

Beta

MNOV0.69

TENX1.00

52W Performance

MNOV24.6%

TENX-76.1%

YTD Performance

MNOV14.3%

TENX-83.1%

% from 52W High

MNOV-61.0%

TENX-90.4%

% from 52W Low

MNOV30.1%

TENX42.7%

Asset Turnover (TTM)

MNOV0.02x

TENX0.00x

FCF Yield (TTM)

MNOV-12.2%

TENX-92.8%

Earnings Yield (TTM)

MNOV-14.4%

TENX-130.7%

Dividend Yield (TTM)

MNOVN/A

TENXN/A

Rule of 40

MNOV-407.5

TENX-82.9

EV/GP/RG

MNOVN/A

TENXN/A

Ticker research

View MNOV research View TENX research

Metric	MNOV MediciNova Inc	TENX Tenax Therapeutics Inc
Market & Valuation
Market Cap	$75M	$50M
Enterprise Value	$49M	$-68M
Price	$1.52	$1.87
P/E Ratio	N/A	N/A
P/S Ratio	81.28x	1,503.03x
EV/Sales	53.67x	-889.99x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.35x	0.65x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.41x	1.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$920K	$0
Revenue Growth (YoY)	583.8%	-82.9%
Forward Rev Growth	-2.9%	111.9%
Profitability
Gross Margin (TTM)	37.8%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1285.4%	0.0%
Net Margin (TTM)	-1168.3%	0.0%
FCF Margin (TTM)	-991.3%	N/A
Net Income (TTM)	$-11M	$-65M
FCF (TTM)	$-9M	$-46M
EPS (TTM)	-$0.22	-$1.28
ROE (TTM)	-2651.0%	-6155.0%
ROA (TTM)	-2439.0%	-5742.0%
ROIC (TTM)	-2651.0%	-6155.0%
Financial Health
Cash	$25M	$118M
Debt	$0	$0
Net Cash/Debt	$25M	$118M
Current Ratio (TTM)	8.75x	15.07x
Quick Ratio (TTM)	8.58x	14.65x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.69	1.00
52W Performance	24.6%	-76.1%
YTD Performance	14.3%	-83.1%
% from 52W High	-61.0%	-90.4%
% from 52W Low	30.1%	42.7%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-12.2%	-92.8%
Earnings Yield (TTM)	-14.4%	-130.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-407.5	-82.9
EV/GP/RG	N/A	N/A
Ticker research	View MNOV research	View TENX research

Valuation

P/S Ratio

MNOV

81.28x

TENX

1,503.03x

EV/FCF

MNOV

-5.41x

TENX

1.49x

Growth & revenue

Revenue Growth TTM

MNOV

583.8%

TENX

-82.9%

Forward Revenue Growth

TENX

111.9%

MNOV

-2.9%

Profitability & performance

Gross Margin

TENX

100.0%

MNOV

37.8%

ROE

MNOV

-2651.0%

TENX

-6155.0%

FCF Yield %

MNOV

-12.2%

TENX

-92.8%

52-Week Performance

MNOV

24.6%

TENX

-76.1%

Detailed metrics comparison

MNOV

MediciNova Inc

TENX

Tenax Therapeutics Inc

Market Cap

MNOV$75M

TENX$50M

Enterprise Value

MNOV$49M

TENX$-68M

Price

MNOV$1.52

TENX$1.87

P/E Ratio

MNOVN/A

TENXN/A

P/S Ratio

MNOV81.28x

TENX1,503.03x

EV/Sales

MNOV53.67x

TENX-889.99x

EV/EBITDA

MNOV0.00x

TENX0.00x

P/B Ratio

MNOV2.35x

TENX0.65x

P/FCF Ratio

MNOVN/A

TENXN/A

EV/FCF

MNOV-5.41x

TENX1.49x

PEG Ratio

MNOVN/A

TENXN/A

Forward P/E (NTM)

MNOVN/A

TENXN/A

Forward P/S (NTM)

MNOVN/A

TENXN/A

Revenue (TTM)

MNOV$920K

TENX$0

Revenue Growth (YoY)

MNOV583.8%

TENX-82.9%

Forward Rev Growth

MNOV-2.9%

TENX111.9%

Gross Margin (TTM)

MNOV37.8%

TENX100.0%

Operating Margin (TTM)

MNOV0.0%

TENX0.0%

EBITDA Margin (TTM)

MNOV-1285.4%

TENX0.0%

Net Margin (TTM)

MNOV-1168.3%

TENX0.0%

FCF Margin (TTM)

MNOV-991.3%

TENXN/A

Net Income (TTM)

MNOV$-11M

TENX$-65M

FCF (TTM)

MNOV$-9M

TENX$-46M

EPS (TTM)

MNOV-$0.22

TENX-$1.28

ROE (TTM)

MNOV-2651.0%

TENX-6155.0%

ROA (TTM)

MNOV-2439.0%

TENX-5742.0%

ROIC (TTM)

MNOV-2651.0%

TENX-6155.0%

Cash

MNOV$25M

TENX$118M

Debt

MNOV$0

TENX$0

Net Cash/Debt

MNOV$25M

TENX$118M

Current Ratio (TTM)

MNOV8.75x

TENX15.07x

Quick Ratio (TTM)

MNOV8.58x

TENX14.65x

Debt/Equity (TTM)

MNOV0.00x

TENX0.00x

Debt/Assets (TTM)

MNOV0.0%

TENX0.0%

Interest Coverage (TTM)

MNOVN/A

TENXN/A

Net Debt/EBITDA (TTM)

MNOV0.00x

TENX0.00x

Beta

MNOV0.69

TENX1.00

52W Performance

MNOV24.6%

TENX-76.1%

YTD Performance

MNOV14.3%

TENX-83.1%

% from 52W High

MNOV-61.0%

TENX-90.4%

% from 52W Low

MNOV30.1%

TENX42.7%

Asset Turnover (TTM)

MNOV0.02x

TENX0.00x

FCF Yield (TTM)

MNOV-12.2%

TENX-92.8%

Earnings Yield (TTM)

MNOV-14.4%

TENX-130.7%

Dividend Yield (TTM)

MNOVN/A

TENXN/A

Rule of 40

MNOV-407.5

TENX-82.9

EV/GP/RG

MNOVN/A

TENXN/A

Ticker research

View MNOV research View TENX research

Metric	MNOV MediciNova Inc	TENX Tenax Therapeutics Inc
Market & Valuation
Market Cap	$75M	$50M
Enterprise Value	$49M	$-68M
Price	$1.52	$1.87
P/E Ratio	N/A	N/A
P/S Ratio	81.28x	1,503.03x
EV/Sales	53.67x	-889.99x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.35x	0.65x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.41x	1.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$920K	$0
Revenue Growth (YoY)	583.8%	-82.9%
Forward Rev Growth	-2.9%	111.9%
Profitability
Gross Margin (TTM)	37.8%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1285.4%	0.0%
Net Margin (TTM)	-1168.3%	0.0%
FCF Margin (TTM)	-991.3%	N/A
Net Income (TTM)	$-11M	$-65M
FCF (TTM)	$-9M	$-46M
EPS (TTM)	-$0.22	-$1.28
ROE (TTM)	-2651.0%	-6155.0%
ROA (TTM)	-2439.0%	-5742.0%
ROIC (TTM)	-2651.0%	-6155.0%
Financial Health
Cash	$25M	$118M
Debt	$0	$0
Net Cash/Debt	$25M	$118M
Current Ratio (TTM)	8.75x	15.07x
Quick Ratio (TTM)	8.58x	14.65x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.69	1.00
52W Performance	24.6%	-76.1%
YTD Performance	14.3%	-83.1%
% from 52W High	-61.0%	-90.4%
% from 52W Low	30.1%	42.7%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-12.2%	-92.8%
Earnings Yield (TTM)	-14.4%	-130.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-407.5	-82.9
EV/GP/RG	N/A	N/A
Ticker research	View MNOV research	View TENX research